NTR
NYSE · Chemicals
Nutrien Ltd
$71.48
-0.73 (-1.01%)
Financial Highlights (FY 2026)
Revenue
36.94B
Net Income
3.12B
Gross Margin
30.1%
Profit Margin
8.4%
Rev Growth
-10.8%
D/E Ratio
0.47
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 30.1% | 30.1% | 46.8% | 46.8% |
| Operating Margin | 13.9% | 12.5% | 8.3% | 8.3% |
| Profit Margin | 8.4% | 8.0% | 8.6% | 8.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 36.94B | 41.42B | 24.90B | 24.03B |
| Gross Profit | 11.11B | 12.46B | 11.65B | 11.24B |
| Operating Income | 5.14B | 5.18B | 2.06B | 1.99B |
| Net Income | 3.12B | 3.14B | 2.14B | 1.94B |
| Gross Margin | 30.1% | 30.1% | 46.8% | 46.8% |
| Operating Margin | 13.9% | 12.5% | 8.3% | 8.3% |
| Profit Margin | 8.4% | 8.0% | 8.6% | 8.1% |
| Rev Growth | -10.8% | -10.8% | +14.2% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 7.69B | 7.69B | 6.63B | 6.41B |
| Total Equity | 16.20B | 16.20B | 20.37B | 20.87B |
| D/E Ratio | 0.47 | 0.47 | 0.33 | 0.31 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 6.16B | 6.56B | 2.29B | 2.51B |
| Free Cash Flow | — | — | 1.46B | 1.43B |